View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Brentuximab Vedotin 1.8 / Dacarbazine 375 - Brentuximab Vedotin 1.8, Hodgkin Lymphoma, Cycle 13-16
Protocol-ID: 2365 V1.0 (Mini), BRNT1.8/DCRB375 - BRNT1.8, Hodgkin, C13-16Indication(s)
- Hodgkin Lymphoma (unfit); ICD-10 C81.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 11.06.2023